EMN vs SYRE

Comparison between Eastman Chemical Company (EMN, Company) and Spyre Therapeutics Inc (SYRE, Company).

EMN is from the Basic Materials sector, while SYRE is from the Healthcare sector.

5-Year PerformanceEMN has outperformed SYRE, delivering a return of -5.6% compared to -7.9%

EMN vs SYRE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	EMN(COMPANY)	SYRE(COMPANY)
Market Cap	$7.68B	$7.72B
Max Drawdown	76.78%	99.11%
Sharpe Ratio	0.02	2.88
5Y Beta	1.09	1.76
Industry	Specialty Chemicals	Biotechnology
P/E Ratio	16.23	-39.65
Forward P/E	10.57	N/A
PEG Ratio	0.58	N/A
Dividend Yield	4.90%	N/A
5Y Dividends CAGR	4.18%	N/A
5Y EPS CAGR	-13.84%	-2.15%
Debt to Equity	86.87%	0.00%
Free Cash Flow Yield	6.48%	-2.41%
P/S Ratio	0.91	650.22
P/B Ratio	1.30	16.86

Market Cap

EMN

$7.68B

Winner

SYRE

$7.72B

Max Drawdown

Winner

EMN

76.78%

SYRE

99.11%

Sharpe Ratio

EMN

0.02

Winner

SYRE

2.88

5Y Beta

Winner

EMN

1.09

SYRE

1.76

Industry

EMN

Specialty Chemicals

SYRE

Biotechnology

P/E Ratio

EMN

16.23

Winner

SYRE

-39.65

Forward P/E

EMN

10.57

SYRE

N/A

PEG Ratio

EMN

0.58

SYRE

N/A

Dividend Yield

EMN

4.90%

SYRE

N/A

5Y Dividends CAGR

EMN

4.18%

SYRE

N/A

5Y EPS CAGR

EMN

-13.84%

Winner

SYRE

-2.15%

Debt to Equity

EMN

86.87%

Winner

SYRE

0.00%

Free Cash Flow Yield

Winner

EMN

6.48%

SYRE

-2.41%

P/S Ratio

Winner

EMN

0.91

SYRE

650.22

P/B Ratio

Winner

EMN

1.30

SYRE

16.86

EMN vs SYRE - Historical Returns

Returns include dividend reinvestment.

Period	EMN	SYRE
1 month	+4.61%	+14.33%
3 months	-3.06%	+36.33%
6 months	+3.45%	+217.39%
1 year	+0.20%	+487.04%
5 years(CAGR)	-5.62%	-7.91%
10 years(CAGR)	+4.12%	-1.66%
Max(CAGR)	+8.51%	-8.16%

EMN

+4.61%

Winner

SYRE

+14.33%

EMN

-3.06%

Winner

SYRE

+36.33%

EMN

+3.45%

Winner

SYRE

+217.39%

EMN

+0.20%

Winner

SYRE

+487.04%

5Y(CAGR)

Winner

EMN

-5.62%

SYRE

-7.91%

10Y(CAGR)

Winner

EMN

+4.12%

SYRE

-1.66%

Max(CAGR)

Winner

EMN

+8.51%

SYRE

-8.16%

EMN vs SYRE - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	EMN	SYRE
2026	+11.46%	+231.92%
2025	-24.53%	+37.36%
2024	+5.62%	+8.79%
2023	+13.61%	+104.27%
2022	-29.62%	-90.57%
2021	+25.71%	-44.51%
2020	+32.48%	+1.55%
2019	+12.06%	-4.98%
2018	-20.50%	+39.22%
2017	+25.08%	+18.38%
2016	+15.91%	-55.48%
2015	-9.67%	N/A
2014	-3.84%	N/A
2013	+17.63%	N/A
2012	+72.68%	N/A
2011	-6.26%	N/A
2010	+39.87%	N/A
2009	+90.79%	N/A
2008	-45.80%	N/A
2007	+4.61%	N/A
2006	+17.28%	N/A
2005	-6.99%	N/A
2004	+51.49%	N/A
2003	+10.46%	N/A
2002	-1.78%	N/A
2001	-14.35%	N/A
2000	+9.36%	N/A
1999	+27.57%	N/A

EMN vs SYRE Drawdown Comparison

The maximum drawdown for EMN was -76.10%, occurring on Mar 5, 2009. Recovery took 588 trading sessions.

The maximum drawdown for SYRE was -99.11%, occurring on Jun 21, 2023. This drawdown has not yet recovered.

The current EMN drawdown is -34.74%. The current SYRE drawdown is -66.14%.

Rank	EMN	SYRE
#1	-76.10% May 20, 2008 - Sep 20, 2010	-99.11% Apr 8, 2016 - Jun 21, 2023
#2	-62.79% Mar 12, 2018 - Nov 24, 2020	N/A
#3	-49.36% Jan 18, 2022 - Nov 20, 2025	N/A
#4	-44.78% May 17, 2001 - Sep 30, 2004	N/A
#5	-37.68% May 10, 2011 - Feb 3, 2012	N/A
#6	-32.81% Jun 4, 2014 - Jun 13, 2017	N/A
#7	-32.78% May 22, 2000 - Mar 7, 2001	N/A
#8	-32.38% Jan 6, 2000 - Apr 28, 2000	N/A
#9	-25.48% Mar 11, 2005 - Oct 27, 2006	N/A
#10	-22.79% Jun 1, 2021 - Jan 18, 2022	N/A
#11	-20.90% Feb 28, 2012 - Aug 7, 2012	N/A
#12	-17.42% Jul 23, 2007 - Apr 8, 2008	N/A
#13	-13.98% Feb 13, 2013 - Jul 15, 2013	N/A
#14	-11.60% Oct 23, 2013 - Feb 13, 2014	N/A
#15	-11.57% Dec 28, 2004 - Feb 25, 2005	N/A